Radiosight develops ultra-wide imaging technology to aid in the diagnosis of skin cancer and to guide surgical decisions.
Radiosight develops ultra-wide imaging technology to aid in the diagnosis of skin cancer and to guide surgical decisions. The company was founded in 2020 and is headquartered in Hoboken, New Jersey.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Apr 21, 2021 | Grant | $256K | 1 |
National Science Foundation
|
— | Detail |
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
National Science Foundation
|
Yes | Grant |